HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH RSS TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Abstract Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Related articles in JNM Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via Google Scholar Google Scholar Articles by de Boer, J. R. Articles by van der Laan, B. F.A.M. Search for Related Content PubMed PubMed Citation Articles by de Boer, J. R. Articles by van der Laan, B. F.A.M.

Prediction of Survival and Therapy Outcome with ¹¹C-Tyrosine PET in Patients with Laryngeal Carcinoma

¹ Department of Otorhinolaryngology and Head and Neck Surgery, Groningen University Hospital, Groningen, The Netherlands
² PET Center of Groningen University Hospital, Groningen, The Netherlands
³ Department of Radiotherapy, Groningen University Hospital, Groningen, The Netherlands

View larger version (52K): [in a new window]   FIGURE 1. Transaxial CT and 11C-TYR PET scans of patient 28, with T3 N0 supraglottic squamous cell carcinoma (1), show increased 11C-TYR uptake in tumor.

View larger version (10K): [in a new window]   FIGURE 2. Cumulative survival of patients with T1–T4 laryngeal carcinomas (n = 34). Differences between patients with tumor PSR equal to or higher than the median (2.0 nmol/mL/min) and patients with tumor PSR lower than the median are demonstrated (P = 0.07).

View larger version (10K): [in a new window]   FIGURE 3. Survival curves (Kaplan-Meier) for patients with laryngeal carcinomas treated with primary radiotherapy (n = 20). Significant differences (P = 0.03) are demonstrated between patients (n = 9) with tumor PSR equal to or higher than the median (2.0 nmol/mL/min) and patients (n = 11) with tumor PSR lower than the median.